APO Research
Talk to an analyst

APO RESEARCH · REPORT

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025180 pages

Choose your research edition.

Industry ResearchGranulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) include Nobelpharma, Partner Therapeutics, Guangzhou Baiyunshan Pharmaceutical, Harbin Pharmaceutical Group, Hainan Unipul Pharmaceutical, North China Pharmaceutical, Amoytop Biotech and Changchun GeneScience Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market size, projected growth trends, production technologies, key applications, and end-use industries.

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Company

Nobelpharma

Partner Therapeutics

Guangzhou Baiyunshan Pharmaceutical

Harbin Pharmaceutical Group

Hainan Unipul Pharmaceutical

North China Pharmaceutical

Amoytop Biotech

Changchun GeneScience Pharmaceutical

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Type

Injection

Inhalation

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Application

Cancer Treatment Support

Infectious Disease Treatment

Proteinosis Autoimmune Pulmonary Alveolar

Other

Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends Table 2. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers Table 3. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges Table 4. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints Table 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Manufacturers Table 9. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers, Product Type & Application Table 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Inhalation Table 18. Major Manufacturers of Other Table 19. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2026) & (K Units) Table 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2027-2032) & (K Units) Table 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2026) Table 23. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2027-2032) Table 24. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2026) & (K Units) Table 26. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2027-2032) & (K Units) Table 27. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2026) Table 28. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Cancer Treatment Support Table 30. Major Manufacturers of Infectious Disease Treatment Table 31. Major Manufacturers of Proteinosis Autoimmune Pulmonary Alveolar Table 32. Major Manufacturers of Other Table 33. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2026) & (K Units) Table 35. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2027-2032) & (K Units) Table 36. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2026) Table 37. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2027-2032) Table 38. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2026) & (K Units) Table 40. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2027-2032) & (K Units) Table 41. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2026) Table 42. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2027-2032) Table 43. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026) & (K Units) Table 45. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Region (2021-2026) Table 46. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 50. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 51. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 53. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2027-2032) & (K Units) Table 60. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021-2026) Table 64. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2027-2032) Table 65. Nobelpharma Company Information Table 66. Nobelpharma Business Overview Table 67. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 69. Nobelpharma Recent Development Table 70. Partner Therapeutics Company Information Table 71. Partner Therapeutics Business Overview Table 72. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 74. Partner Therapeutics Recent Development Table 75. Guangzhou Baiyunshan Pharmaceutical Company Information Table 76. Guangzhou Baiyunshan Pharmaceutical Business Overview Table 77. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 79. Guangzhou Baiyunshan Pharmaceutical Recent Development Table 80. Harbin Pharmaceutical Group Company Information Table 81. Harbin Pharmaceutical Group Business Overview Table 82. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 84. Harbin Pharmaceutical Group Recent Development Table 85. Hainan Unipul Pharmaceutical Company Information Table 86. Hainan Unipul Pharmaceutical Business Overview Table 87. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 89. Hainan Unipul Pharmaceutical Recent Development Table 90. North China Pharmaceutical Company Information Table 91. North China Pharmaceutical Business Overview Table 92. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 94. North China Pharmaceutical Recent Development Table 95. Amoytop Biotech Company Information Table 96. Amoytop Biotech Business Overview Table 97. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 99. Amoytop Biotech Recent Development Table 100. Changchun GeneScience Pharmaceutical Company Information Table 101. Changchun GeneScience Pharmaceutical Business Overview Table 102. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio Table 104. Changchun GeneScience Pharmaceutical Recent Development Table 105. Key Raw Materials Table 106. Raw Materials Key Suppliers Table 107. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors List Table 108. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers List Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Image Figure 2. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size (2021-2032) & (US$ Million) Figure 4. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales (2021-2032) & (K Units) Figure 5. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Inhalation Image Figure 10. Other Image Figure 11. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2032) Figure 14. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2032) Figure 17. Cancer Treatment Support Image Figure 18. Infectious Disease Treatment Image Figure 19. Proteinosis Autoimmune Pulmonary Alveolar Image Figure 20. Other Image Figure 21. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2032) Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2032) Figure 27. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 29. U.S. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 34. Germany Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 41. China Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Country (2021-2032) Figure 49. Brazil Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Figure 60. North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Figure 62. Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Inhalation
  • Other
Applications
  • Cancer Treatment Support
  • Infectious Disease Treatment
  • Proteinosis Autoimmune Pulmonary Alveolar
  • Other
Companies covered
  • Nobelpharma
  • Partner Therapeutics
  • Guangzhou Baiyunshan Pharmaceutical
  • Harbin Pharmaceutical Group
  • Hainan Unipul Pharmaceutical
  • North China Pharmaceutical
  • Amoytop Biotech
  • Changchun GeneScience Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market Dynamics
  1. 2.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Trends
  2. 2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Drivers
  3. 2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Opportunities and Challenges
  4. 2.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Restraints
3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Manufacturers
  1. 3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers, Product Type & Application
  7. 3.7 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Tier 1, Tier 2, and Tier 3
4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Type
  1. 4.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Inhalation
  4. 4.1.3 Other
  5. 4.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type
  6. 4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Type (2021-2032)
  8. 4.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type
  10. 4.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Type (2021-2032)
  12. 4.3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Type (2021-2032)
5 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Market by Application
  1. 5.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Application Introduction
  2. 5.1.1 Cancer Treatment Support
  3. 5.1.2 Infectious Disease Treatment
  4. 5.1.3 Proteinosis Autoimmune Pulmonary Alveolar
  5. 5.1.4 Other
  6. 5.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application
  7. 5.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Application (2021-2032)
  9. 5.2.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application
  11. 5.3.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Application (2021-2032)
  13. 5.3.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Application (2021-2032)
6 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region
  1. 6.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2032)
  3. 6.2.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Region (2021-2026)
  4. 6.2.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region
  1. 7.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region
  2. 7.1.1 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2021-2026)
  4. 7.1.3 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue by Region (2027-2032)
  5. 7.1.4 Global Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032)
  8. 7.2.2 North America Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032)
  11. 7.3.2 Europe Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Nobelpharma
  2. 8.1.1 Nobelpharma Company Information
  3. 8.1.2 Nobelpharma Business Overview
  4. 8.1.3 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Nobelpharma Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  6. 8.1.5 Nobelpharma Recent Developments
  7. 8.2 Partner Therapeutics
  8. 8.2.1 Partner Therapeutics Company Information
  9. 8.2.2 Partner Therapeutics Business Overview
  10. 8.2.3 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Partner Therapeutics Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  12. 8.2.5 Partner Therapeutics Recent Developments
  13. 8.3 Guangzhou Baiyunshan Pharmaceutical
  14. 8.3.1 Guangzhou Baiyunshan Pharmaceutical Company Information
  15. 8.3.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
  16. 8.3.3 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Guangzhou Baiyunshan Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  18. 8.3.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
  19. 8.4 Harbin Pharmaceutical Group
  20. 8.4.1 Harbin Pharmaceutical Group Company Information
  21. 8.4.2 Harbin Pharmaceutical Group Business Overview
  22. 8.4.3 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Harbin Pharmaceutical Group Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  24. 8.4.5 Harbin Pharmaceutical Group Recent Developments
  25. 8.5 Hainan Unipul Pharmaceutical
  26. 8.5.1 Hainan Unipul Pharmaceutical Company Information
  27. 8.5.2 Hainan Unipul Pharmaceutical Business Overview
  28. 8.5.3 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hainan Unipul Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  30. 8.5.5 Hainan Unipul Pharmaceutical Recent Developments
  31. 8.6 North China Pharmaceutical
  32. 8.6.1 North China Pharmaceutical Company Information
  33. 8.6.2 North China Pharmaceutical Business Overview
  34. 8.6.3 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 North China Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  36. 8.6.5 North China Pharmaceutical Recent Developments
  37. 8.7 Amoytop Biotech
  38. 8.7.1 Amoytop Biotech Company Information
  39. 8.7.2 Amoytop Biotech Business Overview
  40. 8.7.3 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Amoytop Biotech Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  42. 8.7.5 Amoytop Biotech Recent Developments
  43. 8.8 Changchun GeneScience Pharmaceutical
  44. 8.8.1 Changchun GeneScience Pharmaceutical Company Information
  45. 8.8.2 Changchun GeneScience Pharmaceutical Business Overview
  46. 8.8.3 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Changchun GeneScience Pharmaceutical Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Product Portfolio
  48. 8.8.5 Changchun GeneScience Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Value Chain Analysis
  2. 9.1.1 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Production Mode & Process
  6. 9.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Distributors
  9. 9.2.3 Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst